Two Sigma Securities’s Bellerophon Therapeutics, Inc. BLPH Stock Holding History

Two Sigma Securities’s Portfolio BLPH Stock Details BLPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-10,355	Closed	-$7.14K	–	3674
2023 Q2	$7.14K	Buy	+10,355	New	+$66.7K	﹤0.01%	2633
2022 Q1	–	Sell	-11,161	Closed	-$35K	–	2699
2021 Q4	$35K	Buy	+11,161	New	+$37.1K	﹤0.01%	1334
2019 Q3	–	Sell	-741	Closed	-$7K	–	2622
2019 Q2	$7K	Sell	741 -799	-52%	-$7.66K	﹤0.01%	2017
2019 Q1	$15K	Buy	+1,540	New	+$17K	﹤0.01%	1699
2018 Q4	–	Sell	-1,823	Closed	-$30K	–	3073
2018 Q3	$30K	Buy	+1,823	New	+$43.3K	﹤0.01%	2397
2018 Q2	–	Sell	-931	Closed	-$29K	–	3156
2018 Q1	$29K	Buy	+931	New	+$29.6K	﹤0.01%	2549
2016 Q3	–	Sell	-858	Closed	-$22K	–	837
2016 Q2	$22K	Buy	+858	New	+$23.5K	0.01%	371

Other funds holding BLPH

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Two Sigma Securities's BLPH Position: Q3 2023 in Review

Two Sigma Securities sold out of Bellerophon Therapeutics, Inc. (BLPH) in Q3 2023, closing a stake of 10,355 shares — an estimated $7.14K sold.

Two Sigma Securities first reported a position in BLPH in Q2 2016 and held it in 7 quarters. The position peaked at $35K in Q4 2021. 22 funds tracked by Wall St. Rank hold BLPH as of Q3 2023.

Two Sigma Securities reported no remaining Bellerophon Therapeutics, Inc. position as of Q3 2023 after selling out during the quarter.
Two Sigma Securities sold 10,355 Bellerophon Therapeutics, Inc. shares in Q3 2023, an estimated $7.14K.
Two Sigma Securities first reported a position in Bellerophon Therapeutics, Inc. in Q2 2016 and held it in 7 quarters.
Two Sigma Securities's Bellerophon Therapeutics, Inc. position peaked at $35K in Q4 2021.
22 funds tracked by Wall St. Rank held Bellerophon Therapeutics, Inc. as of Q3 2023.

Based on Two Sigma Securities's 13F filing for Q3 2023, filed 14 Nov 2023.